The Allergen – Insulin Human by EIA test measures allergen-specific IgE antibodies against human insulin in serum. It helps identify IgE-mediated allergic reactions in individuals who develop hypersensitivity following insulin therapy.
When is this test recommended?
Suspected allergy after insulin injection
Local injection-site redness, swelling, or itching
Generalized hives (urticaria)
Difficulty breathing or suspected anaphylactic reactions
Evaluation before changing insulin formulations
Monitoring patients with suspected insulin hypersensitivity
Symptoms of Insulin Allergy
Itching at the injection site
Redness and swelling
Skin rash or hives
Wheezing or shortness of breath
Facial or throat swelling
Rare severe allergic (anaphylactic) reactions
Preparation
No fasting is required.
Inform your healthcare provider about current insulin therapy and any anti-allergy medications.
Interpretation
Negative: No significant IgE sensitization to human insulin detected.
Positive: Indicates sensitization to human insulin and should be interpreted along with clinical symptoms and medical history.
Benefits
Helps diagnose insulin-related allergic reactions
Assists physicians in selecting appropriate insulin therapy
Supports allergy evaluation and treatment planning
Aids in differentiating allergic reactions from other injection-site complications
Note: A positive result indicates sensitization but does not always confirm clinical allergy. Results should always be interpreted by a qualified healthcare professional in conjunction with the patient's symptoms and clinical findings.